NIAID Funding News, September 7, 2022

September 7, 2022 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news Feature Articles  Understand the Fiscal Year Calendar to Sync Your Timing Recognizing how NIH deadlines correspond to the fiscal year calendar can help you understand when and why NIAID undertakes certain actions and processes. Opportunities and Resources Review NIAID Topics for Small Business Innovation Research Contract Solicitation The solicitation serves as a vehicle for small business offerors to propose research projects on a multitude of scientific topics from across NIH. Contract proposals are due November 4, 2022. New Funding Opportunities Center on Coordinating Centers NIAID seeks to establish three distinct centers through cooperative agreements in the scientific areas of allergy and asthma; transplantation; and clinical data and safety management. Foster Research on Health of Bisexual and Bisexual+ People NIAID and other NIH institutes and centers aim to foster health research training and career development on the health and wellbeing of people who identify as bisexual or bisexual+. In The News Save the Dates—2023 NIH Grants Conference and 2022 Events A new PreCon webinar series gives you multiple opportunities to learn about grant processes and policies, engage with NIH experts, network with your peers, and gather information to use and share. Review and Correct FY 2022 Grant Information by October 3 Grantee organizations should review and verify the accuracy of their grant assignments for Departments or Components within Organizations of Higher Education in eRA Commons. How NIH Plans to Share American Indian and Alaska Native COVID Data Learn how NIH, based on Tribal Consultation feedback, plans to share American Indian and Alaska Native clinical data through the National COVID Cohort Collaborative platform. NIAID Expires Recently Issued HIV Cure Interventions NOSI NIAID expired Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of Antiretroviral Therapy Initiation. Advice Corner NRSA Training Directors—Good News About Childcare Support NIH allows childcare costs for dependent children living in the eligible full-time appointed predoctoral or postdoctoral trainee's home from birth until the age of 13 or, for children who are disabled, until age 18. Reader Questions "Can I watch the NIAID Advisory Council meetings on September 12, 2022?" "What is the 'Research Education Outcomes' attachment for an R25 application?" New Funding Opportunities Mycobacterium tuberculosis (MTB) Quality Assessment Program (TBQA) RFA-OD-22-022, Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24, Clinical Trial Not Allowed) RFA-OD-22-021, Environmental influences on Child Health Outcomes (ECHO) Coordinating Center (U2C, Clinical Trial Not Allowed) RFA-OD-22-020, Environmental influences on Child Health Outcomes (ECHO) Measurement Core (U24, Clinical Trial Not Allowed) RFA-OD-22-019, Limited Competition—Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up (UG3/UH3, Clinical Trial Not Allowed) RFA-OD-22-018, Limited Competition—Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites (UG3/UH3, Clinical Trial Not Allowed) RFA-OD-22-017, Open Competition—Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites (UG3/UH3, Clinical Trial Not Allowed) RFA-OD-22-016, Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24, Clinical Trial Not Allowed) PAR-23-027, CCRP Initiative—NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01, Clinical Trial Not Allowed) RFA-AI-22-055, Maintaining Immunity After Immunization (U01, Clinical Trial Not Allowed) PAR-22-229, Laboratory of Developmental Biology (R24, Clinical Trial Not Allowed) RFA-DA-23-056, Chemical Countermeasures Research Program (CCRP) Initiative—Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01, Clinical Trial Not Allowed) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, September 7, 2022 — Add Comment